Back to Search

ABUS

Arbutus Biopharma Corporation Common Stock
Data: 2026-07-24
$4.38
Price
-2.01%
Change
$5.38
52W High
$3.20
52W Low
Full AI Analysis Buy/Sell Forecast Trendline Why Moving Charts Options

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Quick Stats
Jul 24, 2026

51.7

AI Score

HOLD

0.33

Volume Ratio

Aug 05, 2026

Next Earnings

16

+ve Days (30d)

14

-ve Days (30d)

ABUS Stock Summary

Last updated Jul 24, 2026

ABUS is currently trading at $4.38, positioned below its 200-day moving average of $4.44, suggesting bearish momentum. The stock has a 52-week range of $3.195 to $5.38.

Technical Analysis: The 50-day moving average stands at $4.51, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.28, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.133, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ABUS at 51.7/100 with a HOLD recommendation.

ABUS (Arbutus Biopharma Corporation Common Stock) Indicators

Last updated Jul 24, 2026

Indicator Value
RSI(14) 43.28
CMF (20) 0.133
ROC (10) -8.75
ADX (14) 18.523
Indicator Value
MACD (12,26,9) -0.034
AROONOSC (14) -71.429
WILLAMS %R (14) -88.496
MFI (14) 50.878
ABUS Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

ABUS Price vs Max Options Open Interest
ABUS Max Change In Options Open Interest

ABUS Options - Sort by Max open Interest (near term)

25th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Daily Out of Money Options - Sort by Max open Interest (near term)

25th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Daily In the Money Options - Sort by Max open Interest (near term)

25th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI		 Volume Ask PC Delta Vega Volatility % change Track

ABUS Most Active Options by Volume(near term)

25th July 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI		 Ask PC Delta Vega Volatility % change Track

Arbutus Biopharma Corporation Common Stock is below both the 50 Day and 200 Day SMA which is considered Bearish.

ABUS Moving Averages Analysis

ABUS (Arbutus Biopharma Corporation Common Stock) Simple Moving Averages

Moving Averages are last updated Jul 24, 2026

Days MA
10 4.52
20 4.71
30 4.61
50 4.51
100 4.46
200 4.44

ABUS Fundamental Analysis

P/E (Forward) 10.2459
P/E (Trailing) 5.1977
Market Cap ($) 883.0 million
Earnings/Share ($) 0.86
Net Profit Margin (%) 0.8395
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.219
EPS Estimate Next Year ($) -0.124
WallStreet Target Price ($) 5.17
Most Recent Quarter